نتائج البحث - Hengyu Lu

  • يعرض 1 - 11 نتائج من 11
تنقيح النتائج
  1. 1
    Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR

    Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR حسب Hengyu Lu, Chen Liu, Hung Huynh, Thi Bich Uyen Le, Matthew J. LaMarche, Morvarid Mohseni, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Huai‐Xiang Hao

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors

    SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors حسب Hengyu Lu, Chen Liu, Roberto Velazquez, Hongyun Wang, Lukas Manuel Dunkl, Malika Kazic-Legueux, Anne Haberkorn, Éric Billy, Eusebio Manchado, Saskia M. Brachmann, Susan E. Moody, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro, Morvarid Mohseni, Huai‐Xiang Hao

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing

    Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing حسب Lixing Yang, Mi-Sook Lee, Hengyu Lu, Doo‐Yi Oh, Yeon Jeong Kim, Donghyun Park, Gahee Park, Xiaojia Ren, Christopher A. Bristow, Psalm Haseley, Soohyun Lee, Angeliki Pantazi, Raju Kucherlapati, Woong‐Yang Park, Kenneth L. Scott, Yoon‐La Choi, Peter J. Park

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma

    RET Fusion as a Novel Driver of Medullary Thyroid Carcinoma حسب Elizabeth G. Grubbs, Patrick Kwok‐Shing Ng, Jacquelin H. Bui, Naifa L. Busaidy, Ken Chen, Jeffrey E. Lee, Xinyan Lu, Hengyu Lu, Funda Meric‐Bernstam, Gordon B. Mills, Gary A. Palmer, Nancy D. Perrier, Kenneth L. Scott, Kenna Shaw, Steven G. Waguespack, Michelle D. Williams, Roman Yelensky, Gilbert J. Cote

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer

    In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer حسب Caitlin L. Grzeskowiak, Samrat T. Kundu, Xiulei Mo, Andrei A. Ivanov, Oksana Zagorodna, Hengyu Lu, Richard H. Chapple, Yiu Huen Tsang, Daniela Moreno, M. Mosqueda, Karina Eterovic, Jared J. Fradette, S Ahmad, Fengju Chen, Zechen Chong, Ken Chen, Chad J. Creighton, Haian Fu, Gordon B. Mills, Don L. Gibbons, Kenneth L. Scott

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling

    Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling حسب Chen Liu, Hengyu Lu, Hongyun Wang, Alice Loo, Xiamei Zhang, Guizhi Yang, Colleen Kowal, Scott Delach, Ye Wang, Silvia Goldoni, William D. Hastings, Karrie Wong, Hui Gao, Matthew J. Meyer, Susan E. Moody, Matthew J. LaMarche, Jeffrey A. Engelman, Juliet Williams, Peter S. Hammerman, Tinya J. Abrams, Morvarid Mohseni, Giordano Caponigro, Huai‐Xiang Hao

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Functional annotation of rare gene aberration drivers of pancreatic cancer

    Functional annotation of rare gene aberration drivers of pancreatic cancer حسب Yiu Huen Tsang, Turgut Dogruluk, Philip M. Tedeschi, Joanna Wardwell‐Ozgo, Hengyu Lu, Maribel Espitia, Nikitha Nair, Rosalba Minelli, Zechen Chong, Fengju Chen, Qing Chang, Jennifer B. Dennison, Armel Dogruluk, Min Li, Haoqiang Ying, Joseph R. Bertino, Marie-Claude Gingras, Michael Ittmann, John E. Kerrigan, Ken Chen, Chad J. Creighton, Karina Eterovic, Gordon B. Mills, Kenneth L. Scott

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Dual Allosteric Inhibition of SHP2 Phosphatase

    Dual Allosteric Inhibition of SHP2 Phosphatase حسب Michelle Fodor, Edmund V. Price, Ping Wang, Hengyu Lu, Andreea Argintaru, Zhouliang Chen, Meir Glick, Huai‐Xiang Hao, Mitsunori Kato, Robert Koenig, Jonathan R. LaRochelle, Gang Liu, Eric McNeill, Dyuti Majumdar, Gisele Nishiguchi, Lawrence Perez, Grégory Paris, Christopher M. Quinn, Timothy M. Ramsey, Martin Sendzik, Michael D. Shultz, Sarah Williams, Travis Stams, Stephen C. Blacklow, Michael Acker, Matthew J. LaMarche

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers

    Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers حسب Huai‐Xiang Hao, Hongyun Wang, Chen Liu, Steven Kovats, Roberto Velazquez, Hengyu Lu, Bhavesh Pant, Matthew D. Shirley, Matthew J. Meyer, Minying Pu, Joanne Lim, Michael S. Fleming, LeighAnn Alexander, Ali Farsidjani, Matthew J. LaMarche, Susan E. Moody, Serena J. Silver, Giordano Caponigro, Darrin D. Stuart, Tinya J. Abrams, Peter S. Hammerman, Juliet Williams, Jeffrey A. Engelman, Silvia Goldoni, Morvarid Mohseni

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Combined KRAS<sup>G12C</sup>and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistance

    Combined KRAS<sup>G12C</sup>and SOS1 inhibition enhances and extends the anti-tumor response in KRAS<sup>G12C</sup>-driven cancers by addressing intrinsic and acquired resistance حسب Venu Thatikonda, Hengyu Lu, Sabine Jurado, Kaja Kostyrko, Christopher A. Bristow, Karin Bosch, Ningping Feng, Sisi Gao, Daniel Gerlach, Michael Gmachl, Simone Lieb, Astrid Jeschko, Annette A. Machado, Ethan D. Marszalek, Mikhila Mahendra, Philipp A. Jaeger, Alexey V. Sorokin, Sandra J. Strauss, Francesca Trapani, Scott Kopetz, Christopher P. Vellano, Mark Petronczki, Norbert Kraut, Timothy P. Heffernan, Joseph R. Marszalek, Mark Pearson, Irene C. Waizenegger, Marco H. Hofmann

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Pré-impressão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Systematic Functional Annotation of Somatic Mutations in Cancer

    Systematic Functional Annotation of Somatic Mutations in Cancer حسب Patrick Kwok‐Shing Ng, Jun Li, Kang Jin Jeong, Shan Shao, Hu Chen, Yiu Huen Tsang, Sohini Sengupta, Zixing Wang, Venkata Hemanjani Bhavana, Richard Tran, Stephanie Soewito, Darlan Conterno Minussi, Daniela Moreno, Kathleen Kong, Turgut Dogruluk, Hengyu Lu, Jianjiong Gao, Collin Tokheim, Daniel Cui Zhou, Amber M. Johnson, Jia Zeng, Carman K. M. Ip, Zhenlin Ju, Matthew Wester, Shuangxing Yu, Yongsheng Li, Christopher P. Vellano, Nikolaus Schultz, Rachel Karchin, Li Ding, Yiling Lu, Lydia W.T. Cheung, Ken Chen, Kenna Shaw, Funda Meric‐Bernstam, Kenneth L. Scott, S. Stephen Yi, Nidhi Sahni, Han Liang, Gordon B. Mills

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: